We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    gog 0238
Previous Study | Return to List | Next Study

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

This study is currently recruiting participants.
Verified August 2017 by Gynecologic Oncology Group
Sponsor:
ClinicalTrials.gov Identifier:
NCT00492778
First Posted: June 27, 2007
Last Update Posted: August 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group
  Purpose
This randomized phase II trial studies radiation therapy and cisplatin to see how well they work compared with radiation therapy alone in treating patients with endometrial cancer that has come back. Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving radiation therapy together with cisplatin is more effective than radiation therapy alone in treating patients with endometrial cancer.

Condition Intervention Phase
Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma Radiation: 3-Dimensional Conformal Radiation Therapy Drug: Cisplatin Radiation: Intensity-Modulated Radiation Therapy Radiation: Internal Radiation Therapy Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus

Resource links provided by NLM:


Further study details as provided by Gynecologic Oncology Group:

Primary Outcome Measures:
  • Duration of progression-free survival [ Time Frame: From study entry until disease progression, death, or date of last contact, assessed up to 5 years ]

Secondary Outcome Measures:
  • Duration of overall survival [ Time Frame: From entry into the study to death or the date of last contact, assessed up to 5 years ]
  • Incidence of adverse effects graded by CTCAE version 3.0 [ Time Frame: Up to 5 years ]
  • Prognostic significance of tumor size, tumor location (vaginal only vs. all others) and histology [ Time Frame: Up to 5 years ]
    Additionally, age, race, and tumor grade will be evaluated as prognostic factors. These analyses will help to define the appropriate population with sufficient risk for future studies involving therapy that is more aggressive. A proportional hazards model adjusted for performance status and treatment will be used to explore the relationship between these variables and progression-free survival or survival.


Estimated Enrollment: 164
Actual Study Start Date: February 25, 2008
Estimated Primary Completion Date: July 1, 2022 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm I (brachytherapy, radiation therapy)
Patients undergo EBRT to the pelvis daily on days 1-5 for 5 weeks. After completion of EBRT, patients undergo intracavitary low-dose rate or high-dose rate brachytherapy or low-dose rate interstitial brachytherapy.
Radiation: 3-Dimensional Conformal Radiation Therapy
Given to the pelvis
Radiation: Intensity-Modulated Radiation Therapy
Undergo IMRT
Radiation: Internal Radiation Therapy
Given intracavitarily or interstitially
Experimental: Arm II (brachytherapy, radiation therapy, cisplatin)
Patients undergo EBRT as in Arm I and receive cisplatin IV over 1-2 hours on days 1, 8, 15, 22, and 29. Patients then undergo brachytherapy as in Arm I.
Radiation: 3-Dimensional Conformal Radiation Therapy
Given to the pelvis
Drug: Cisplatin
Given IV
Radiation: Intensity-Modulated Radiation Therapy
Undergo IMRT
Radiation: Internal Radiation Therapy
Given intracavitarily or interstitially

Detailed Description:

PRIMARY OBJECTIVES:

I. To assess whether pelvic radiation therapy with concurrent cisplatin is more promising with respect to progression-free survival than pelvic radiation therapy alone in the treatment of recurrent uterine carcinoma limited to the pelvis and vagina.

SECONDARY OBJECTIVES:

I. To capture the sites of recurrence subsequent to treatment with pelvic radiation with or without concurrent weekly cisplatin in women with recurrent uterine carcinoma.

II. To estimate overall survival of patients with recurrent uterine carcinoma treated with pelvic radiation therapy with or without concurrent weekly cisplatin.

III. To estimate the prognostic significance of the location (central pelvis versus vagina) and size of the recurrence, in addition to the prognostic significance in the salvage setting of the histological subtype, grade, patient age, race, performance status, and the presence of lymph-vascular space involvement of the original tumor at the time of initial hysterectomy.

IV. To evaluate toxicity derived from the combined cisplatin and radiation compared with radiation alone in this patient population.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients undergo external-beam radiotherapy (EBRT) to the pelvis daily on days 1-5 for 5 weeks. After completion of EBRT, patients undergo intracavitary low-dose rate or high-dose rate brachytherapy* or low-dose rate interstitial brachytherapy*.

ARM II: Patients undergo EBRT as in Arm I and receive cisplatin intravenously (IV) over 1-2 hours on days 1, 8, 15, 22, and 29. Patients then undergo brachytherapy* as in Arm I.

NOTE: *IMRT boost is allowed for patients who are not candidates for brachytherapy. IMRT may also be used for the entire course of therapy for the treatment of the whole pelvis and/or the boost in patients not undergoing brachytherapy. In both arms, treatment continues in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients must have undergone complete hysterectomy and bilateral salpingo-oophorectomy at the time of original therapy for their uterine carcinoma
  • Patients must have a biopsy with histologically confirmed diagnosis of recurrent endometrial cancer confined to the pelvis and/or vagina and no evidence of extrapelvic disease
  • Patients must have endometrial carcinoma including endometrioid adenocarcinoma, adenocarcinoma with squamous differentiation, mucinous adenocarcinoma, squamous cell carcinoma, mixed carcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, and serous adenocarcinoma histologies
  • Patients must have no evidence of extrapelvic disease; complete workup staging should be performed prior to initiation of therapy to rule-out presence of metastatic disease; this should include: computed tomography (CT) scan of the thorax with IV contrast, as well as a CT of the pelvis and abdomen with IV and oral (PO) contrast performed using multi-detector CT and equal or less than 5 mm slice thickness; if the patient is unable to tolerate contrast, then magnetic resonance imaging (MRI) with IV gadolinium should be performed; a chest x-ray should be done first, and if abnormal, then a CT scan of the chest should be done
  • Primary surgical debulking before protocol therapy is permissible; this would include removal of gross symptomatic disease in the pelvis and/or vagina

    • Exenterative surgery is not permissible; patients with complete resection of gross recurrent disease are eligible
  • Patients may have received prior hormone therapy and/or systemic chemotherapy; such therapy must have been completed at least 6 months prior to study entry and the patient has clear evidence of disease subsequent to such therapy; patients must not have received neoadjuvant chemotherapy for the present recurrent disease
  • Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
  • Patients must have an estimated survival greater or equal to 3 months
  • Absolute neutrophil count (ANC) >= 1,500/mm^3 , equivalent to Common Toxicity Criteria (Common Terminology Criteria for Adverse Events [CTCAE] version [v] 3.0) grade 1
  • Platelets >= 100,000/mm^3, equivalent to CTCAE v 3.0 grade 0-1
  • Creatinine =< institutional upper limit normal (ULN), CTCAE v 3.0 grade 0; NOTE: if creatinine > ULN, creatinine clearance must be > 50 mL/min
  • Bilirubin =< 1.5 x ULN (CTCAE v 3.0 grade 1)
  • Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN (CTCAE v 3.0 grade 0-1)
  • Alkaline phosphatase =< 2.5 x ULN (CTCAE v 3.0 grade 0-1)
  • Neuropathy (sensory and motor) =< CTCAE v 3.0 grade 1
  • Patients with ureteral obstruction must undergo stent or nephrostomy tube placement prior to study entry
  • Patients who have met the pre-entry requirements
  • Patients must have signed an approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Exclusion Criteria:

  • Patients with evidence of disease outside of the pelvis, including presence of positive periaortic or inguino-femoral nodes
  • Patients who have received previous vaginal, pelvic, or abdominal irradiation
  • Patients who received chemotherapy directed at the present recurrence
  • Patients with septicemia or severe infection
  • Patients who have circumstances that will not permit completion of this study or the required follow-up
  • Patients with renal abnormalities, such as pelvic kidney, horseshoe kidney, or renal transplantation, that would require modification of radiation fields
  • Patients with a history of other invasive malignancies, with the exception of non-melanoma skin cancer, are excluded if there is any evidence of other malignancy being present within the last five years; patients are also excluded if their previous cancer treatment contraindicates this protocol therapy
  • Patients who have undergone complete surgical resection of the recurrent tumor and have no evidence of residual disease evaluable clinically and by CT or MRI imaging, following resection
  • Patients who have a significant history of cardiac disease, i.e., uncontrolled hypertension, unstable angina, congestive heart failure, or uncontrolled arrhythmias within 6 months of registration
  • Patients with history of active collagen vascular disease
  • Patients with GOG performance grade of 3 or 4
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00492778


  Hide Study Locations
Locations
United States, California
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Cancer Centers Radiation Oncology Services-Auburn Recruiting
Auburn, California, United States, 95603
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Alta Bates Summit Medical Center-Herrick Campus Recruiting
Berkeley, California, United States, 94704
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Providence Saint Joseph Medical Center/Disney Family Cancer Center Suspended
Burbank, California, United States, 91505
Mills-Peninsula Medical Center Recruiting
Burlingame, California, United States, 94010
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Cancer Centers Radiation Oncology Services-Cameron Park Recruiting
Cameron Park, California, United States, 95682
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Eden Hospital Medical Center Recruiting
Castro Valley, California, United States, 94546
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Davis Hospital Recruiting
Davis, California, United States, 95616
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
UC San Diego Moores Cancer Center Suspended
La Jolla, California, United States, 92093
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Scott E. Lentz    626-564-3455      
Principal Investigator: Scott E. Lentz         
Memorial Medical Center Recruiting
Modesto, California, United States, 95355
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Palo Alto Medical Foundation-Camino Division Recruiting
Mountain View, California, United States, 94040
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Palo Alto Medical Foundation-Gynecologic Oncology Recruiting
Mountain View, California, United States, 94040
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Cancer Research Consortium Suspended
Novato, California, United States, 94945
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Cancer Centers Radiation Oncology Services-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Roseville Medical Center Recruiting
Roseville, California, United States, 95661
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Medical Center Sacramento Recruiting
Sacramento, California, United States, 95816
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
University of California Davis Comprehensive Cancer Center Suspended
Sacramento, California, United States, 95817
University of California San Diego Active, not recruiting
San Diego, California, United States, 92103
California Pacific Medical Center-Pacific Campus Recruiting
San Francisco, California, United States, 94115
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Pacific Medical Foundation Suspended
Santa Rosa, California, United States, 95403
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Olive View-University of California Los Angeles Medical Center Suspended
Sylmar, California, United States, 91342
Sutter Cancer Centers Radiation Oncology Services-Vacaville Recruiting
Vacaville, California, United States, 95687
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
Sutter Solano Medical Center/Cancer Center Recruiting
Vallejo, California, United States, 94589
Contact: Stacy D. D'Andre    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Stacy D. D'Andre         
United States, Colorado
University of Colorado Cancer Center - Anschutz Cancer Pavilion Active, not recruiting
Aurora, Colorado, United States, 80045
United States, Connecticut
Hartford Hospital Suspended
Hartford, Connecticut, United States, 06102
Smilow Cancer Hospital Care Center at Saint Francis Suspended
Hartford, Connecticut, United States, 06105
The Hospital of Central Connecticut Suspended
New Britain, Connecticut, United States, 06050
United States, Delaware
Beebe Medical Center Recruiting
Lewes, Delaware, United States, 19958
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Gynecologic Oncology LLC Suspended
Newark, Delaware, United States, 19713
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Regional Hematology and Oncology PA Recruiting
Newark, Delaware, United States, 19713
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Beebe Health Campus Recruiting
Rehoboth Beach, Delaware, United States, 19971
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Nanticoke Memorial Hospital Recruiting
Seaford, Delaware, United States, 19973
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
Christiana Care Health System-Wilmington Hospital Recruiting
Wilmington, Delaware, United States, 19801
Contact: Mark E. Borowsky    302-733-6227      
Principal Investigator: Mark E. Borowsky         
United States, District of Columbia
Sibley Memorial Hospital Suspended
Washington, D.C., District of Columbia, United States, 20016
United States, Florida
Sarasota Memorial Hospital Suspended
Sarasota, Florida, United States, 34239
United States, Georgia
Northside Hospital Suspended
Atlanta, Georgia, United States, 30342
Augusta University Medical Center Recruiting
Augusta, Georgia, United States, 30912
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Northeast Georgia Medical Center-Gainesville Recruiting
Gainesville, Georgia, United States, 30501
Contact: Andrew E. Green    770-219-8800    cancerpatient.navigator@nghs.com   
Principal Investigator: Andrew E. Green         
Memorial University Medical Center Recruiting
Savannah, Georgia, United States, 31404
Contact: James J. Burke    912-350-8568      
Principal Investigator: James J. Burke         
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Suspended
Savannah, Georgia, United States, 31405
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Alphonsus Cancer Care Center-Caldwell Recruiting
Caldwell, Idaho, United States, 83605
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Kootenai Medical Center Recruiting
Coeur d'Alene, Idaho, United States, 83814
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Walter Knox Memorial Hospital Recruiting
Emmett, Idaho, United States, 83617
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Idaho Urologic Institute-Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Alphonsus Medical Center-Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Kootenai Cancer Center Recruiting
Post Falls, Idaho, United States, 83854
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Kootenai Cancer Clinic Recruiting
Sandpoint, Idaho, United States, 83864
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
United States, Illinois
Rush - Copley Medical Center Suspended
Aurora, Illinois, United States, 60504
Saint Joseph Medical Center Suspended
Bloomington, Illinois, United States, 61701
Illinois CancerCare-Bloomington Suspended
Bloomington, Illinois, United States, 61704
Illinois CancerCare-Canton Suspended
Canton, Illinois, United States, 61520
Illinois CancerCare-Carthage Suspended
Carthage, Illinois, United States, 62321
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Shohreh Shahabi    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Shohreh Shahabi         
Rush University Medical Center Recruiting
Chicago, Illinois, United States, 60612
Contact: Jessica Zhou    312-942-5498    clinical_trials@rush.edu   
Principal Investigator: Jessica Zhou         
University of Chicago Comprehensive Cancer Center Suspended
Chicago, Illinois, United States, 60637
Heartland Cancer Research NCORP Terminated
Decatur, Illinois, United States, 62526
Illinois CancerCare-Eureka Suspended
Eureka, Illinois, United States, 61530
NorthShore University HealthSystem-Evanston Hospital Recruiting
Evanston, Illinois, United States, 60201
Contact: Jean A. Hurteau    847-570-2109      
Principal Investigator: Jean A. Hurteau         
Illinois CancerCare-Galesburg Suspended
Galesburg, Illinois, United States, 61401
Western Illinois Cancer Treatment Center Suspended
Galesburg, Illinois, United States, 61401
Northwestern Medicine Cancer Center Delnor Recruiting
Geneva, Illinois, United States, 60134
Contact: LaToya J. Perry    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: LaToya J. Perry         
Sudarshan K Sharma MD Limted-Gynecologic Oncology Recruiting
Hinsdale, Illinois, United States, 60521
Contact: Sudarshan K. Sharma    630-654-1790    info@hhoaltd.com   
Principal Investigator: Sudarshan K. Sharma         
Joliet Oncology-Hematology Associates Limited Suspended
Joliet, Illinois, United States, 60435
Illinois CancerCare-Kewanee Clinic Suspended
Kewanee, Illinois, United States, 61443
Illinois CancerCare-Macomb Suspended
Macomb, Illinois, United States, 61455
Loyola University Medical Center Recruiting
Maywood, Illinois, United States, 60153
Contact: Matthew M. Harkenrider    708-202-8387      
Principal Investigator: Matthew M. Harkenrider         
Garneau, Stewart C MD (UIA Investigator) Recruiting
Moline, Illinois, United States, 61265
Contact: David M. Spector    563-359-9876      
Principal Investigator: David M. Spector         
Spector, David MD (UIA Investigator) Recruiting
Moline, Illinois, United States, 61265
Contact: David M. Spector    563-359-9876      
Principal Investigator: David M. Spector         
Trinity Medical Center Recruiting
Moline, Illinois, United States, 61265
Contact: David M. Spector    563-359-9876      
Principal Investigator: David M. Spector         
Illinois CancerCare-Monmouth Suspended
Monmouth, Illinois, United States, 61462
Bromenn Regional Medical Center Suspended
Normal, Illinois, United States, 61761
Community Cancer Center Foundation Suspended
Normal, Illinois, United States, 61761
Advocate Christ Medical Center Recruiting
Oak Lawn, Illinois, United States, 60453-2699
Contact: Renee H. Jacobs    800-323-8622      
Principal Investigator: Renee H. Jacobs         
Illinois CancerCare-Ottawa Clinic Suspended
Ottawa, Illinois, United States, 61350
Ottawa Regional Hospital and Healthcare Center Suspended
Ottawa, Illinois, United States, 61350
Illinois CancerCare-Pekin Suspended
Pekin, Illinois, United States, 61554
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center Suspended
Pekin, Illinois, United States, 61554
Methodist Medical Center of Illinois Suspended
Peoria, Illinois, United States, 61603
Illinois CancerCare-Peoria Suspended
Peoria, Illinois, United States, 61615
OSF Saint Francis Radiation Oncology at Peoria Cancer Center Suspended
Peoria, Illinois, United States, 61615
OSF Saint Francis Medical Center Suspended
Peoria, Illinois, United States, 61637
Illinois CancerCare-Peru Suspended
Peru, Illinois, United States, 61354
Valley Radiation Oncology Suspended
Peru, Illinois, United States, 61354
Illinois CancerCare-Princeton Suspended
Princeton, Illinois, United States, 61356
Carle Cancer Center Withdrawn
Urbana, Illinois, United States, 61801
Northwestern Medicine Cancer Center Warrenville Recruiting
Warrenville, Illinois, United States, 60555
Contact: LaToya J. Perry    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: LaToya J. Perry         
United States, Indiana
Indiana University/Melvin and Bren Simon Cancer Center Suspended
Indianapolis, Indiana, United States, 46202
Franciscan Saint Anthony Health-Michigan City Suspended
Michigan City, Indiana, United States, 46360
Memorial Regional Cancer Center Day Road Recruiting
Mishawaka, Indiana, United States, 46545
Contact: Nonyem A. Onujiogu    800-284-7370      
Principal Investigator: Nonyem A. Onujiogu         
Memorial Hospital of South Bend Recruiting
South Bend, Indiana, United States, 46601
Contact: Nonyem A. Onujiogu    800-284-7370      
Principal Investigator: Nonyem A. Onujiogu         
United States, Iowa
Constantinou, Costas L MD (UIA Investigator) Recruiting
Bettendorf, Iowa, United States, 52722
Contact: David M. Spector    563-359-9876      
Principal Investigator: David M. Spector         
Mercy Hospital Recruiting
Cedar Rapids, Iowa, United States, 52403
Contact: Deborah W. Wilbur    319-365-4673      
Principal Investigator: Deborah W. Wilbur         
Oncology Associates at Mercy Medical Center Recruiting
Cedar Rapids, Iowa, United States, 52403
Contact: Deborah W. Wilbur    319-365-4673      
Principal Investigator: Deborah W. Wilbur         
Medical Oncology and Hematology Associates-West Des Moines Suspended
Clive, Iowa, United States, 50325
Mercy Cancer Center-West Lakes Suspended
Clive, Iowa, United States, 50325
Iowa Methodist Medical Center Suspended
Des Moines, Iowa, United States, 50309
Iowa-Wide Oncology Research Coalition NCORP Active, not recruiting
Des Moines, Iowa, United States, 50309
Medical Oncology and Hematology Associates-Des Moines Suspended
Des Moines, Iowa, United States, 50309
Medical Oncology and Hematology Associates-Laurel Suspended
Des Moines, Iowa, United States, 50314
Mercy Medical Center - Des Moines Suspended
Des Moines, Iowa, United States, 50314
Iowa Lutheran Hospital Suspended
Des Moines, Iowa, United States, 50316
University of Iowa/Holden Comprehensive Cancer Center Recruiting
Iowa City, Iowa, United States, 52242
Contact: David P. Bender    800-237-1225      
Principal Investigator: David P. Bender         
Siouxland Regional Cancer Center Recruiting
Sioux City, Iowa, United States, 51101
Contact: Donald B. Wender    712-252-0088      
Principal Investigator: Donald B. Wender         
Mercy Medical Center-Sioux City Suspended
Sioux City, Iowa, United States, 51104
Saint Luke's Regional Medical Center Suspended
Sioux City, Iowa, United States, 51104
Methodist West Hospital Suspended
West Des Moines, Iowa, United States, 50266-7700
Mercy Medical Center-West Lakes Suspended
West Des Moines, Iowa, United States, 50266
United States, Kansas
Cancer Center of Kansas - Chanute Recruiting
Chanute, Kansas, United States, 66720
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Dodge City Recruiting
Dodge City, Kansas, United States, 67801
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - El Dorado Recruiting
El Dorado, Kansas, United States, 67042
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Fort Scott Recruiting
Fort Scott, Kansas, United States, 66701
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Independence Recruiting
Independence, Kansas, United States, 67301
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Providence Medical Center Suspended
Kansas City, Kansas, United States, 66112
Cancer Center of Kansas-Kingman Recruiting
Kingman, Kansas, United States, 67068
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Kansas Institute of Medicine Cancer and Blood Center Recruiting
Lenexa, Kansas, United States, 66219
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Minimally Invasive Surgery Hospital Recruiting
Lenexa, Kansas, United States, 66219
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Cancer Center of Kansas-Liberal Recruiting
Liberal, Kansas, United States, 67905
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Manhattan Recruiting
Manhattan, Kansas, United States, 66502
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - McPherson Recruiting
McPherson, Kansas, United States, 67460
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Newton Recruiting
Newton, Kansas, United States, 67114
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Menorah Medical Center Recruiting
Overland Park, Kansas, United States, 66209
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Saint Luke's South Hospital Recruiting
Overland Park, Kansas, United States, 66213
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Cancer Center of Kansas - Parsons Recruiting
Parsons, Kansas, United States, 67357
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Kansas City NCI Community Oncology Research Program Recruiting
Prairie Village, Kansas, United States, 66208
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Cancer Center of Kansas - Pratt Recruiting
Pratt, Kansas, United States, 67124
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Salina Recruiting
Salina, Kansas, United States, 67401
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wellington Recruiting
Wellington, Kansas, United States, 67152
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Associates In Womens Health Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Wichita Medical Arts Tower Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wichita Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Via Christi Regional Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Wesley Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Wichita NCI Community Oncology Research Program Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Winfield Recruiting
Winfield, Kansas, United States, 67156
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
United States, Kentucky
Saint Elizabeth Medical Center South Recruiting
Edgewood, Kentucky, United States, 41017
Contact: Jack B. Basil    859-301-5473    darla.hehman@stelizabeth.com   
Principal Investigator: Jack B. Basil         
University of Kentucky/Markey Cancer Center Recruiting
Lexington, Kentucky, United States, 40536
Contact: Frederick R. Ueland    859-257-3379      
Principal Investigator: Frederick R. Ueland         
United States, Louisiana
Woman's Hospital Suspended
Baton Rouge, Louisiana, United States, 70817
United States, Maine
Maine Medical Center-Bramhall Campus Suspended
Portland, Maine, United States, 04102
Maine Medical Center- Scarborough Campus Recruiting
Scarborough, Maine, United States, 04074
Contact: Christopher J. Darus    207-885-7565      
Principal Investigator: Christopher J. Darus         
United States, Maryland
Greater Baltimore Medical Center Suspended
Baltimore, Maryland, United States, 21204
Sinai Hospital of Baltimore Suspended
Baltimore, Maryland, United States, 21215
Union Hospital of Cecil County Suspended
Elkton, Maryland, United States, 21921
United States, Massachusetts
Lahey Hospital and Medical Center Suspended
Burlington, Massachusetts, United States, 01805
Baystate Medical Center Suspended
Springfield, Massachusetts, United States, 01199
University of Massachusetts Memorial Health Care Suspended
Worcester, Massachusetts, United States, 01605
University of Massachusetts Medical School Suspended
Worcester, Massachusetts, United States, 01655
United States, Michigan
Bixby Medical Center Suspended
Adrian, Michigan, United States, 49221
Hickman Cancer Center Suspended
Adrian, Michigan, United States, 49221
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106-0995
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Michigan Cancer Research Consortium NCORP Terminated
Ann Arbor, Michigan, United States, 48106
IHA Hematology Oncology Consultants-Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Canton Recruiting
Canton, Michigan, United States, 48188
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Canton Health Center Recruiting
Canton, Michigan, United States, 48188
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Caro Cancer Center Recruiting
Caro, Michigan, United States, 48723
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Hematology Oncology Consultants-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Beaumont Hospital-Dearborn Recruiting
Dearborn, Michigan, United States, 48124
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Robert T. Morris    313-576-9363      
Principal Investigator: Robert T. Morris         
Saint John Hospital and Medical Center Recruiting
Detroit, Michigan, United States, 48236
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Doctors Park Recruiting
East China Township, Michigan, United States, 48054
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Weisberg Cancer Treatment Center Recruiting
Farmington Hills, Michigan, United States, 48334
Contact: Robert T. Morris    313-576-9363      
Principal Investigator: Robert T. Morris         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48502
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Genesee Cancer and Blood Disease Treatment Center Recruiting
Flint, Michigan, United States, 48503
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Genesee Hematology Oncology PC Recruiting
Flint, Michigan, United States, 48503
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Genesys Regional Medical Center-West Flint Campus Suspended
Flint, Michigan, United States, 48532
Genesys Regional Medical Center Suspended
Grand Blanc, Michigan, United States, 48439
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Lymphoma Clinic of Michigan Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Grosse Pointe Woods Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Allegiance Health Recruiting
Jackson, Michigan, United States, 49201
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Borgess Medical Center Recruiting
Kalamazoo, Michigan, United States, 49001
Contact: Sunil Nagpal    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Sunil Nagpal         
Bronson Methodist Hospital Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Sunil Nagpal    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Sunil Nagpal         
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Sunil Nagpal    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Sunil Nagpal         
Sparrow Hospital Recruiting
Lansing, Michigan, United States, 48912
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Hope Cancer Clinic Recruiting
Livonia, Michigan, United States, 48154
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Hematology Oncology Associates East PC Recruiting
Macomb, Michigan, United States, 48044
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Macomb Township Recruiting
Macomb, Michigan, United States, 48044
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Toledo Clinic Cancer Centers-Monroe Suspended
Monroe, Michigan, United States, 48162
21st Century Oncology-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Hope Cancer Center Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Lake Huron Medical Center Suspended
Port Huron, Michigan, United States, 48060
Great Lakes Cancer Management Specialists-Rochester Hills Recruiting
Rochester Hills, Michigan, United States, 48309
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Oncology Hematology Associates of Saginaw Valley PC Recruiting
Saginaw, Michigan, United States, 48604
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Bhadresh Nayak MD PC-Sterling Heights Recruiting
Sterling Heights, Michigan, United States, 48312
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Macomb Professional Building Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Macomb Hematology Oncology PC Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Warren Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Saint Mary's Oncology/Hematology Associates of West Branch Recruiting
West Branch, Michigan, United States, 48661
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Huron Gastroenterology PC Recruiting
Ypsilanti, Michigan, United States, 48106
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Ann Arbor Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
United States, Minnesota
Fairview Ridges Hospital Suspended
Burnsville, Minnesota, United States, 55337
Mercy Hospital Suspended
Coon Rapids, Minnesota, United States, 55433
Fairview-Southdale Hospital Suspended
Edina, Minnesota, United States, 55435
Unity Hospital Suspended
Fridley, Minnesota, United States, 55432
Hutchinson Area Health Care Suspended
Hutchinson, Minnesota, United States, 55350
Minnesota Oncology Hematology PA-Maplewood Suspended
Maplewood, Minnesota, United States, 55109
Saint John's Hospital - Healtheast Suspended
Maplewood, Minnesota, United States, 55109
Abbott-Northwestern Hospital Suspended
Minneapolis, Minnesota, United States, 55407
Hennepin County Medical Center Suspended
Minneapolis, Minnesota, United States, 55415
Health Partners Inc Suspended
Minneapolis, Minnesota, United States, 55454
New Ulm Medical Center Suspended
New Ulm, Minnesota, United States, 56073
North Memorial Medical Health Center Suspended
Robbinsdale, Minnesota, United States, 55422
Metro Minnesota Community Oncology Research Consortium Terminated
Saint Louis Park, Minnesota, United States, 55416
Park Nicollet Clinic - Saint Louis Park Suspended
Saint Louis Park, Minnesota, United States, 55416
Regions Hospital Suspended
Saint Paul, Minnesota, United States, 55101
United Hospital Suspended
Saint Paul, Minnesota, United States, 55102
Saint Francis Regional Medical Center Suspended
Shakopee, Minnesota, United States, 55379
Lakeview Hospital Suspended
Stillwater, Minnesota, United States, 55082
Ridgeview Medical Center Suspended
Waconia, Minnesota, United States, 55387
Rice Memorial Hospital Suspended
Willmar, Minnesota, United States, 56201
Minnesota Oncology Hematology PA-Woodbury Suspended
Woodbury, Minnesota, United States, 55125
United States, Mississippi
University of Mississippi Medical Center Suspended
Jackson, Mississippi, United States, 39216
Singing River Hospital Recruiting
Pascagoula, Mississippi, United States, 39581
Contact: James E. Clarkson    228-809-5292      
Principal Investigator: James E. Clarkson         
United States, Missouri
University of Missouri - Ellis Fischel Suspended
Columbia, Missouri, United States, 65212
Centerpoint Medical Center LLC Recruiting
Independence, Missouri, United States, 64057
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Saint Luke's Hospital of Kansas City Recruiting
Kansas City, Missouri, United States, 64111
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Heartland Hematology and Oncology Associates Incorporated Suspended
Kansas City, Missouri, United States, 64118
Research Medical Center Recruiting
Kansas City, Missouri, United States, 64132
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Saint Luke's East - Lee's Summit Recruiting
Lee's Summit, Missouri, United States, 64086
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Liberty Radiation Oncology Center Suspended
Liberty, Missouri, United States, 64068
Saint John's Clinic-Rolla-Cancer and Hematology Suspended
Rolla, Missouri, United States, 65401
Heartland Regional Medical Center Recruiting
Saint Joseph, Missouri, United States, 64506
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Saint Joseph Oncology Inc Suspended
Saint Joseph, Missouri, United States, 64507
Barnes-Jewish Hospital Suspended
Saint Louis, Missouri, United States, 63110
Washington University School of Medicine Suspended
Saint Louis, Missouri, United States, 63110
Cancer Research for the Ozarks NCORP Terminated
Springfield, Missouri, United States, 65804
Mercy Hospital Springfield Recruiting
Springfield, Missouri, United States, 65804
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
CoxHealth South Hospital Recruiting
Springfield, Missouri, United States, 65807
Contact: Jay W. Carlson    888-221-4849      
Principal Investigator: Jay W. Carlson         
United States, Montana
Community Hospital of Anaconda Recruiting
Anaconda, Montana, United States, 59711
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Billings Clinic Cancer Center Recruiting
Billings, Montana, United States, 59101
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Vincent Healthcare Suspended
Billings, Montana, United States, 59101
Montana Cancer Consortium NCORP Recruiting
Billings, Montana, United States, 59102
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint James Community Hospital and Cancer Treatment Center Suspended
Butte, Montana, United States, 59701
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Great Falls Clinic Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Peter's Community Hospital Recruiting
Helena, Montana, United States, 59601
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Kalispell Regional Medical Center Recruiting
Kalispell, Montana, United States, 59901
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Saint Patrick Hospital - Community Hospital Suspended
Missoula, Montana, United States, 59802
Community Medical Hospital Recruiting
Missoula, Montana, United States, 59804
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
United States, Nebraska
Nebraska Methodist Hospital Recruiting
Omaha, Nebraska, United States, 68114
Contact: Peter C. Morris    402-354-5144      
Principal Investigator: Peter C. Morris         
United States, Nevada
Cancer and Blood Specialists-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
21st Century Oncology - Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Southeast Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
University Medical Center of Southern Nevada Recruiting
Las Vegas, Nevada, United States, 89102
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Shadow Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Nevada Cancer Research Foundation CCOP Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Central Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
21st Century Oncology Recruiting
Las Vegas, Nevada, United States, 89109
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway Recruiting
Las Vegas, Nevada, United States, 89109
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-San Martin Recruiting
Las Vegas, Nevada, United States, 89113
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Southeast Recruiting
Las Vegas, Nevada, United States, 89119
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Cancer Therapy and Integrative Medicine Recruiting
Las Vegas, Nevada, United States, 89121
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Northwest Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Summerlin Recruiting
Las Vegas, Nevada, United States, 89144
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Medical Center Recruiting
Las Vegas, Nevada, United States, 89148-2405
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
21st Century Oncology - Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Nevada Cancer Specialists-Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills Recruiting
Las Vegas, Nevada, United States, 89149
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Central Valley Recruiting
Las Vegas, Nevada, United States, 89169
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
Women's Cancer Center of Nevada Recruiting
Las Vegas, Nevada, United States, 89169
Contact: Nicola M. Spirtos    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Nicola M. Spirtos         
21st Century Oncology - Vegas Tenaya Recruiting
Las Vegas, Nevada, United States, 89182
Contact: John A. Ellerton    805-474-9143      
Principal Investigator: John A. Ellerton         
United States, New Hampshire
Wentworth-Douglass Hospital Suspended
Dover, New Hampshire, United States, 03820
Dartmouth Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Leslie R. DeMars    800-639-6918    cancer.research.nurse@dartmouth.edu   
Principal Investigator: Leslie R. DeMars         
Elliot Hospital Recruiting
Manchester, New Hampshire, United States, 03103
Contact: Brian R. Knab    603-663-1800      
Principal Investigator: Brian R. Knab         
United States, New Jersey
Cooper Hospital University Medical Center Suspended
Camden, New Jersey, United States, 08103
Virtua Memorial Recruiting
Mount Holly, New Jersey, United States, 08060
Contact: Randolph B. Deger    609-914-6762      
Principal Investigator: Randolph B. Deger         
Jersey Shore Medical Center Recruiting
Neptune City, New Jersey, United States, 07753
Contact: Karim S. ElSahwi    732-776-4240      
Principal Investigator: Karim S. ElSahwi         
Rutgers New Jersey Medical School Suspended
Newark, New Jersey, United States, 07101
The Valley Hospital-Luckow Pavilion Recruiting
Paramus, New Jersey, United States, 07652
Contact: Noah A. Goldman    201-634-5792    cparish@valleyhealth.com   
Principal Investigator: Noah A. Goldman         
Saint Luke's Hospital-Warren Campus Recruiting
Phillipsburg, New Jersey, United States, 08865
Contact: David F. Silver    718-765-2500      
Principal Investigator: David F. Silver         
Valley Hospital Recruiting
Ridgewood, New Jersey, United States, 07450
Contact: Noah A. Goldman    201-634-5792    cparish@valleyhealth.com   
Principal Investigator: Noah A. Goldman         
Community Medical Center Suspended
Toms River, New Jersey, United States, 08755
MD Anderson Cancer Center at Cooper-Voorhees Suspended
Voorhees, New Jersey, United States, 08043
Virtua Voorhees Recruiting
Voorhees, New Jersey, United States, 08043
Contact: Randolph B. Deger    609-914-6762      
Principal Investigator: Randolph B. Deger         
Valley Health System-Hematology/Oncology Recruiting
Westwood, New Jersey, United States, 07675
Contact: Noah A. Goldman    201-634-5792    cparish@valleyhealth.com   
Principal Investigator: Noah A. Goldman         
United States, New Mexico
University of New Mexico Cancer Center Suspended
Albuquerque, New Mexico, United States, 87102
Southwest Gynecologic Oncology Associates Inc Suspended
Albuquerque, New Mexico, United States, 87106
United States, New York
State University of New York Downstate Medical Center Recruiting
Brooklyn, New York, United States, 11203
Contact: Ovadia Abulafia    718-613-8324    seema.chittalae@downstate.edu   
Principal Investigator: Ovadia Abulafia         
North Shore University Hospital Recruiting
Manhasset, New York, United States, 11030
Contact: Veena S. John    516-734-8954    vvincigu@northwell.edu   
Principal Investigator: Veena S. John         
Long Island Jewish Medical Center Recruiting
New Hyde Park, New York, United States, 11040
Contact: Veena S. John    516-734-8954    vvincigu@northwell.edu   
Principal Investigator: Veena S. John         
North Shore-LIJ Health System/Center for Advanced Medicine Recruiting
New Hyde Park, New York, United States, 11040
Contact: Veena S. John    516-734-8954    vvincigu@northwell.edu   
Principal Investigator: Veena S. John         
Highland Hospital Recruiting
Rochester, New York, United States, 14620
Contact: Richard G. Moore    585-341-8113      
Principal Investigator: Richard G. Moore         
University of Rochester Recruiting
Rochester, New York, United States, 14642
Contact: Richard G. Moore    585-341-8113      
Principal Investigator: Richard G. Moore         
Stony Brook University Medical Center Recruiting
Stony Brook, New York, United States, 11794
Contact: Michael L. Pearl    800-862-2215      
Principal Investigator: Michael L. Pearl         
State University of New York Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Mary J. Cunningham    315-464-5476      
Principal Investigator: Mary J. Cunningham         
United States, North Carolina
Novant Health Presbyterian Medical Center Recruiting
Charlotte, North Carolina, United States, 28204
Contact: John M. McDonald    704-384-5369      
Principal Investigator: John M. McDonald         
Southeastern Medical Oncology Center-Clinton Recruiting
Clinton, North Carolina, United States, 28328
Contact: James N. Atkins    252-399-7491      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Goldsboro Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    252-399-7491      
Principal Investigator: James N. Atkins         
Wayne Memorial Hospital Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    252-399-7491      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Jacksonville Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: James N. Atkins    252-399-7491      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Wilson Suspended
Wilson, North Carolina, United States, 27893
Wake Forest University Health Sciences Suspended
Winston-Salem, North Carolina, United States, 27157
United States, Ohio
Summa Akron City Hospital/Cooper Cancer Center Suspended
Akron, Ohio, United States, 44304
UHHS-Chagrin Highlands Medical Center Suspended
Beachwood, Ohio, United States, 44122
Strecker Cancer Center-Belpre Recruiting
Belpre, Ohio, United States, 45714
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Aultman Health Foundation Suspended
Canton, Ohio, United States, 44710
Adena Regional Medical Center Recruiting
Chillicothe, Ohio, United States, 45601
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
University of Cincinnati/Barrett Cancer Center Recruiting
Cincinnati, Ohio, United States, 45219
Contact: Eric L. Eisenhauer    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: Eric L. Eisenhauer         
Good Samaritan Hospital - Cincinnati Suspended
Cincinnati, Ohio, United States, 45220
Bethesda North Hospital Suspended
Cincinnati, Ohio, United States, 45242
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Contact: Steven E. Waggoner    800-641-2422      
Principal Investigator: Steven E. Waggoner         
Cleveland Clinic Cancer Center/Fairview Hospital Suspended
Cleveland, Ohio, United States, 44111
Cleveland Clinic Foundation Suspended
Cleveland, Ohio, United States, 44195
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: David M. O'Malley    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: David M. O'Malley         
Mount Carmel East Hospital Recruiting
Columbus, Ohio, United States, 43213
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Columbus NCI Community Oncology Research Program Terminated
Columbus, Ohio, United States, 43215
Grant Medical Center Recruiting
Columbus, Ohio, United States, 43215
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Mount Carmel Health Center West Recruiting
Columbus, Ohio, United States, 43222
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Doctors Hospital Recruiting
Columbus, Ohio, United States, 43228
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Grandview Hospital Recruiting
Dayton, Ohio, United States, 45405
Contact: Thomas J. Reid    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: Thomas J. Reid         
Delaware Health Center-Grady Cancer Center Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Delaware Radiation Oncology Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Grady Memorial Hospital Recruiting
Delaware, Ohio, United States, 43015
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Kettering Medical Center Suspended
Kettering, Ohio, United States, 45429
Fairfield Medical Center Recruiting
Lancaster, Ohio, United States, 43130
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Lancaster Radiation Oncology Terminated
Lancaster, Ohio, United States, 43130
OhioHealth Mansfield Hospital Recruiting
Mansfield, Ohio, United States, 44903
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
OneHealth Marion General Hospital Recruiting
Marion, Ohio, United States, 43302
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Toledo Clinic Cancer Centers-Maumee Suspended
Maumee, Ohio, United States, 43537
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center Suspended
Maumee, Ohio, United States, 43537
Hillcrest Hospital Cancer Center Suspended
Mayfield Heights, Ohio, United States, 44124
Ireland Cancer Center Landerbrook Health Center Suspended
Mayfield Heights, Ohio, United States, 44124
Lake University Ireland Cancer Center Recruiting
Mentor, Ohio, United States, 44060
Contact: Steven E. Waggoner    800-641-2422      
Principal Investigator: Steven E. Waggoner         
Knox Community Hospital Recruiting
Mount Vernon, Ohio, United States, 43050
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Newark Radiation Oncology Recruiting
Newark, Ohio, United States, 43055
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
Saint Charles Hospital Suspended
Oregon, Ohio, United States, 43616
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Springfield Regional Medical Center Suspended
Springfield, Ohio, United States, 45505
Flower Hospital Recruiting
Sylvania, Ohio, United States, 43560
Contact: Jeffrey H. Muler    419-824-1842      
Principal Investigator: Jeffrey H. Muler         
The Toledo Hospital/Toledo Children's Hospital Recruiting
Toledo, Ohio, United States, 43606
Contact: Jeffrey H. Muler    419-824-1842      
Principal Investigator: Jeffrey H. Muler         
University of Toledo Suspended
Toledo, Ohio, United States, 43614
Toledo Community Hospital Oncology Program CCOP Suspended
Toledo, Ohio, United States, 43617
Mercy Saint Anne Hospital Suspended
Toledo, Ohio, United States, 43623
Toledo Clinic Cancer Centers-Toledo Suspended
Toledo, Ohio, United States, 43623
University Hospitals Sharon Health Center Suspended
Wadsworth, Ohio, United States, 44281
Saint Ann's Hospital Recruiting
Westerville, Ohio, United States, 43081
Contact: John P. Kuebler    614-566-3275      
Principal Investigator: John P. Kuebler         
UHHS-Westlake Medical Center Suspended
Westlake, Ohio, United States, 44145
Genesis Healthcare System Cancer Care Center Recruiting
Zanesville, Ohio, United States, 43701
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
United States, Oklahoma
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Robert S. Mannel    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Robert S. Mannel         
Oklahoma Cancer Specialists and Research Institute-Tulsa Suspended
Tulsa, Oklahoma, United States, 74146
United States, Oregon
Saint Alphonsus Medical Center-Baker City Recruiting
Baker City, Oregon, United States, 97814
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Legacy Mount Hood Medical Center Suspended
Gresham, Oregon, United States, 97030
Saint Alphonsus Medical Center-Ontario Recruiting
Ontario, Oregon, United States, 97914
Contact: Philip J. Stella    734-712-4673      
Principal Investigator: Philip J. Stella         
Legacy Good Samaritan Hospital and Medical Center Suspended
Portland, Oregon, United States, 97210
Providence Portland Medical Center Suspended
Portland, Oregon, United States, 97213
Legacy Meridian Park Hospital Suspended
Tualatin, Oregon, United States, 97062
United States, Pennsylvania
Abington Memorial Hospital Recruiting
Abington, Pennsylvania, United States, 19001
Contact: Joel I. Sorosky    215-481-2402      
Principal Investigator: Joel I. Sorosky         
Lehigh Valley Hospital-Cedar Crest Recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Alyson F. McIntosh    610-402-2273      
Principal Investigator: Alyson F. McIntosh         
Saint Luke's University Hospital-Bethlehem Campus Suspended
Bethlehem, Pennsylvania, United States, 18015
Lehigh Valley Hospital - Muhlenberg Recruiting
Bethlehem, Pennsylvania, United States, 18017
Contact: Alyson F. McIntosh    610-402-2273      
Principal Investigator: Alyson F. McIntosh         
Bryn Mawr Hospital Suspended
Bryn Mawr, Pennsylvania, United States, 19010
Geisinger Medical Center Suspended
Danville, Pennsylvania, United States, 17822
Delaware County Memorial Hospital Suspended
Drexel Hill, Pennsylvania, United States, 19026
Adams Cancer Center Recruiting
Gettysburg, Pennsylvania, United States, 17325
Contact: Mark A. Miller    877-441-7957      
Principal Investigator: Mark A. Miller         
Cherry Tree Cancer Center Recruiting
Hanover, Pennsylvania, United States, 17331
Contact: Mark A. Miller    877-441-7957      
Principal Investigator: Mark A. Miller         
Paoli Memorial Hospital Suspended
Paoli, Pennsylvania, United States, 19301
Fox Chase Cancer Center Suspended
Philadelphia, Pennsylvania, United States, 19111
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Bernice L. Robinson-Bennett    610-988-9323      
Principal Investigator: Bernice L. Robinson-Bennett         
Geisinger Wyoming Valley/Henry Cancer Center Suspended
Wilkes-Barre, Pennsylvania, United States, 18711
Lankenau Medical Center Recruiting
Wynnewood, Pennsylvania, United States, 19096
Contact: Paul B. Gilman    484-476-2649    wellenbachj@mlhs.org   
Principal Investigator: Paul B. Gilman         
Main Line Health NCORP Withdrawn
Wynnewood, Pennsylvania, United States, 19096
WellSpan Health-York Cancer Center Recruiting
York, Pennsylvania, United States, 17403
Contact: Mark A. Miller    877-441-7957      
Principal Investigator: Mark A. Miller         
WellSpan Health-York Hospital Recruiting
York, Pennsylvania, United States, 17403
Contact: Mark A. Miller    877-441-7957      
Principal Investigator: Mark A. Miller         
United States, South Carolina
Greenville Health System Cancer Institute-Easley Recruiting
Easley, South Carolina, United States, 29640
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Andrews Suspended
Greenville, South Carolina, United States, 29605
Greenville Health System Cancer Institute-Butternut Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Faris Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Memorial Hospital Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Eastside Recruiting
Greenville, South Carolina, United States, 29615
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Greer Recruiting
Greer, South Carolina, United States, 29650
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Seneca Recruiting
Seneca, South Carolina, United States, 29672
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
Greenville Health System Cancer Institute-Spartanburg Recruiting
Spartanburg, South Carolina, United States, 29307
Contact: Jeffrey W. Elder    864-679-3966      
Principal Investigator: Jeffrey W. Elder         
United States, South Dakota
Avera Cancer Institute Suspended
Sioux Falls, South Dakota, United States, 57105
United States, Tennessee
Chattanooga Gynecological Oncology Suspended
Chattanooga, Tennessee, United States, 37403
University of Tennessee - Knoxville Recruiting
Knoxville, Tennessee, United States, 37920
Contact: Larry C. Kilgore    865-544-9773      
Principal Investigator: Larry C. Kilgore         
United States, Texas
Parkland Memorial Hospital Recruiting
Dallas, Texas, United States, 75235
Contact: David S. Miller    214-590-5582      
Principal Investigator: David S. Miller         
UT Southwestern/Simmons Cancer Center-Dallas Recruiting
Dallas, Texas, United States, 75390
Contact: David S. Miller    214-590-5582      
Principal Investigator: David S. Miller         
M D Anderson Cancer Center Suspended
Houston, Texas, United States, 77030
Memorial Hermann Texas Medical Center Recruiting
Houston, Texas, United States, 77030
Contact: Joseph A. Lucci    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Joseph A. Lucci         
The Methodist Hospital System Recruiting
Houston, Texas, United States, 77030
Contact: Aparna A. Kamat    713-790-2700      
Principal Investigator: Aparna A. Kamat         
Methodist Willowbrook Hospital Recruiting
Houston, Texas, United States, 77070
Contact: Aparna A. Kamat    713-790-2700      
Principal Investigator: Aparna A. Kamat         
Houston Methodist Sugar Land Hospital Recruiting
Sugar Land, Texas, United States, 77479
Contact: Aparna A. Kamat    713-790-2700      
Principal Investigator: Aparna A. Kamat         
United States, Utah
Huntsman Cancer Institute/University of Utah Recruiting
Salt Lake City, Utah, United States, 84112
Contact: David K. Gaffney    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: David K. Gaffney         
South Jordan Health Center Recruiting
South Jordan, Utah, United States, 84009
Contact: David K. Gaffney    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: David K. Gaffney         
United States, Vermont
University of Vermont Medical Center Suspended
Burlington, Vermont, United States, 05401
University of Vermont College of Medicine Suspended
Burlington, Vermont, United States, 05405
United States, Washington
Legacy Salmon Creek Hospital Suspended
Vancouver, Washington, United States, 98686
United States, Wisconsin
Green Bay Oncology at Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301-3526
Contact: Jonathan E. Tammela    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Jonathan E. Tammela         
Saint Vincent Hospital Cancer Center Green Bay Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Jonathan E. Tammela    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Jonathan E. Tammela         
Green Bay Oncology Limited at Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Jonathan E. Tammela    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Jonathan E. Tammela         
Saint Vincent Hospital Cancer Center at Saint Mary's Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Jonathan E. Tammela    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Jonathan E. Tammela         
Gundersen Lutheran Medical Center Recruiting
La Crosse, Wisconsin, United States, 54601
Contact: Alcee J. Jumonville    608-775-2385    cancerctr@gundersenhealth.org   
Principal Investigator: Alcee J. Jumonville         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: David M. Kushner    800-622-8922      
Principal Investigator: David M. Kushner         
Aurora Saint Luke's Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53215
Contact: Elizabeth L. Dickson Michelson    414-649-5717      
Principal Investigator: Elizabeth L. Dickson Michelson         
Cancer Center of Western Wisconsin Suspended
New Richmond, Wisconsin, United States, 54017
Aurora West Allis Medical Center Recruiting
West Allis, Wisconsin, United States, 53227
Contact: Elizabeth L. Dickson Michelson    414-649-5717      
Principal Investigator: Elizabeth L. Dickson Michelson         
United States, Wyoming
Rocky Mountain Oncology Suspended
Casper, Wyoming, United States, 82609
Big Horn Basin Cancer Center Suspended
Cody, Wyoming, United States, 82414
Billings Clinic-Cody Recruiting
Cody, Wyoming, United States, 82414
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Welch Cancer Center Recruiting
Sheridan, Wyoming, United States, 82801
Contact: Benjamin T. Marchello    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: Benjamin T. Marchello         
Canada, Quebec
CHUM - Hopital Notre-Dame Suspended
Montreal, Quebec, Canada, H2L 4M1
Sponsors and Collaborators
Gynecologic Oncology Group
National Cancer Institute (NCI)
Investigators
Principal Investigator: Jonathan Feddock NRG Oncology
  More Information

Responsible Party: Gynecologic Oncology Group
ClinicalTrials.gov Identifier: NCT00492778     History of Changes
Other Study ID Numbers: GOG-0238
NCI-2009-00603 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
CDR0000550975
GOG-0238 ( Other Identifier: NRG Oncology )
GOG-0238 ( Other Identifier: CTEP )
U10CA180868 ( U.S. NIH Grant/Contract )
U10CA027469 ( U.S. NIH Grant/Contract )
First Submitted: June 25, 2007
First Posted: June 27, 2007
Last Update Posted: August 23, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Carcinoma
Adenocarcinoma
Carcinoma, Endometrioid
Cystadenocarcinoma, Serous
Uterine Neoplasms
Adenocarcinoma, Clear Cell
Carcinoma, Adenosquamous
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Endometrial Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Ovarian Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Cystadenocarcinoma
Neoplasms, Cystic, Mucinous, and Serous
Uterine Diseases
Neoplasms, Complex and Mixed
Cisplatin
Antineoplastic Agents


To Top